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Abstract Isolation and characterization of the cDNA coding
for the 216-residue Xenopus laevis prion protein is reported.
Existence of this protein in amphibians was suggested by an EST
fragment (accession number BG813008), while a conclusive
demonstration is presented here. This protein exhibits a higher
identity level to avian and turtle prion (more than 44%) than to
mammalian prion (about 28%). Although most of the structural
motifs common to known prion proteins are conserved in X.
laevis, the lack of repeats represents a substantial difference.
Other features worth noting are the presence of not perfectly
conserved hydrophobic stretch, which is considered the prion
signature, as well as the complete absence of histidine
residues. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Prion protein is a normal cellular protein (PrPc) exhibiting
unique properties, due to its ability of adopting, in particular
conditions, an abnormal conformation. This conformational
shift changes a physiological protein (PrPc) to a pathological
protein isoform, liable for several neurodegenerative diseases,
called transmissible spongiform encephalopathies, described
up to now in mammalian species [1^4]. The well known epi-
demic appearance of such a disease in cattle (bovine spongi-
form encephalopathy) some years ago and its likely transmis-
sion to humans, by feeding infected meals, disclosed new
potential problems in food safety [5]. Consequently, also
non-mammalian species and especially those of large food-
consumption became of interest. Among eatable vertebrate
species, besides mammals and birds, ¢sh occupy the most
important position and, moreover, for a number of species,
¢sh-breedings have been developed. Therefore, obvious ques-
tions have been raised about ¢sh PrP existence as well as
infectivity considerations. No sequence similar to mammalian
PrP has been found until now in any ¢sh species.
PrP has been well characterized in a number of mammalian
species, showing a high degree of primary structure identity
and, in some cases, three-dimensional structure has been re-
solved by nuclear magnetic resonance (NMR) [6]. The ¢rst
non-mammalian PrP was identi¢ed in 1991, by chance, in
chicken. This protein conserves all structural motifs present
in mammalian PrP, despite a low identity level of the primary
structure [7,8]. As far as structural features are concerned,
similar comments ¢t even for turtle PrP sequence, identi¢ed
several years later [9], representing the ¢rst example of such
protein in reptiles, which precedes birds and mammals from
an evolutionary point of view. During the past 2 years, a
number of novel bird PrP cDNAs have been reported, con-
¢rming high identity levels among deduced amino acid se-
quences inside the same zoological class [10]. On the contrary,
no PrP sequences have been described in reptile species other
than the turtle.
Although it is apparent that troubles are encountered in
¢nding more primitive PrPs, the importance of ¢nding them
in lower vertebrates goes beyond a speculative point of view.
Very recently a Xenopus laevis expressed sequence appeared
in EST database, corresponding to a portion of the ¢rst am-
phibian PrP (GenBank/EMBL/DDBJ accession number
BG813008) (Washington University Xenopus EST Project).
Again, in addition to chicken PrP, an important progress
came from a search not speci¢cally addressed.
In this paper the whole cDNA sequence of X. laevis PrP is
reported. Moreover, both the nucleotide and the deduced ami-
no acid sequences are analyzed in comparison with known
PrPs.
2. Materials and methods
2.1. Reverse transcription (RT)-polymerase chain reaction (PCR) and
PCR assays
Oligonucleotides used for PCR assays and for sequencing were
purchased by MWG Biotech, Germany, and are listed in Table 1.
Total RNA was extracted from X. laevis liver using the Chomczyn-
ski and Sacchi method [11]. 3 Wg of total RNA were reverse tran-
scribed using the SuperScript II Reverse Transcriptase (Life Technol-
ogies, UK) and di¡erent primers, depending on experimental
purposes. PCRs were carried out using Platinum Taq DNA polymer-
ase (Life Technologies, UK) in a total volume of 50 Wl containing 1U
bu¡er (20 mM Tris^HCl, pH 8.4; 50 mM KCl), 1.5 mM MgCl2, 200
WM dNTPs and 0.4 WM of each primer. All PCR assays were per-
formed following the producer protocol with an annealing temper-
ature of 5‡C below the minimum melting temperature and an elonga-
tion time ranging from 30 s to 2 min depending on the length of the
expected fragment.
The 3P-end of cDNA was isolated using 3P-RACE as described
previously [12]. Genomic DNA was extracted from liver of X. laevis
using a standard method [13]. PCR assays were carried out on 200 ng
of DNA template as described above.
2.2. DNA sequence analysis
Sequence analysis of the DNA fragments was performed on both
strands directly on puri¢ed PCR products by the Taq dye-deoxy ter-
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minator method, using an automated 3100 DNA sequencer (Applera,
USA).
The cDNA sequence of X. laevis PrP has been deposited in the
EMBL database under accession number AJ320186.
2.3. Computer assisted analysis
DNA sequences were analyzed using MT Navigator PPC software
(release 1.0.2b3) and alignments were performed with PC-GENE (re-
lease 15) and Omiga (release 1.0) software.
Secondary and tertiary structure predictions were performed using
the program ProModII at the SWISS-MODEL Automated Protein
Modelling Server (http://www.expasy.ch/swissmod/swiss-model.html).
3. Results and discussion
A X. laevis expressed sequence (GenBank/EMBL/DDBJ
BG813008) was deposited very recently in EST database.
This DNA fragment, spanning 538 bp, comprises 151 bp of
5P-UTR and 387 bp of the coding sequence. The encoded
peptide (129 amino acids) exhibits some features of known
PrPs, for this reason it has been identi¢ed as partial sequence
belonging to PrP. The above sequence was the starter of this
work, aimed to obtain the whole cDNA coding region.
Existence of PrP in amphibians has therefore been sug-
gested by this X. laevis EST fragment, while a conclusive
demonstration is presented here.
3.1. Isolation and analysis of the whole coding sequence
As ¢rst control for the presence of PrP coding sequence in
total RNA extracted from liver, using EF1/ER1 primer cou-
ple, a 273-bp fragment was ampli¢ed, corresponding to posi-
tions 13^285 of the cDNA sequence shown in Fig. 1 which
will always be used as reference for numbering. This cDNA
was completed by 3P-RACE using semi-nested PCR: a same
3P-primer (FR), annealing to the anchor sequence (AdT), was
coupled in two consecutive PCR assays with XF1 and then
XF2 speci¢c forward oligonucleotides. This procedure led to a
product of 412 bp which overlapped the 3P-end of the EST
DNA fragment with its 5P-end and comprised the lacking part
of the coding sequence (264 bp) as well as a short 3P-UTR.
This cDNA segment corresponds to positions 356^748. A fur-
ther PCR assay was aimed to: (i) encompass the sequence
lying between the 3P-portion of the ¢rst 273-bp fragment
and the 5P-portion of the novel part of cDNA; and (ii) extend
our sequence towards the 5P-end of cDNA. For this purpose a
forward primer (EF2) was designed within 5P-UTR, on the
basis of the EST sequence, while a reverse primer (XR1)
was located within the 3P-region of the coding sequence newly
isolated. A 556-bp DNA fragment was obtained, correspond-
ing to positions 399 to +457.
Some features of the 847-nt cDNA, reported in Fig. 1, need
to be analyzed. The 5P-UTR exhibits two consecutive ATG at
its 3P-end. The ¢rst ATG is likely to be part of the 3P-end of
5P-UTR, because it is preceded by three pyrimidines (TTT), as
it is known that a pyrimidine at the 33 position is an unfa-
vorable context for translation initiation. Consequently, it has
to be supposed that the second ATG with a purine at the
same 33 position represents the true, or at least the main
translation start codon, considering also that the presence of
A and C, immediately after the two ATGs, have the same
value for starting translation [14,15]. Furthermore, when com-
pared to the EST fragment, our 5P-UTR sequence exhibits a
19-nt insertion (positions 331 to 314) which represents a
perfect direct repeat of an upstream sequence (positions 350
to 333), separated by only one nucleotide. Within the coding
region, alternative presence of G or A has been found at
position 43, depending on individuals, leading to a codon
change. The presence of a very short 3P-UTR (79 nt) is sur-
prising, since, in a number of reported mRNAs coding for
PrPs, this region is usually rather long. A putative poly-ad-
enylation (polyA) signal TATAAA [16] is present at positions
702^707, followed, after 23 nt, by 18 adenylates which could
represent a partial polyA tail. Nevertheless, it cannot be ex-
cluded that the here reported X. laevis cDNA is an alternative
transcript, generated by the use of the above polyA signal.
Several attempts of extending 3P-UTR have been unsuccessful.
A PCR assay, carried out on genomic DNA using EF1/
XR2 primer couple, gave a product spanning the same size
exhibited by the corresponding cDNA and subsequent se-
quence analysis con¢rmed that this 714-bp fragment was not
Table 1
Oligonucleotides used as primers in PCR assays
Primer Sequence
EF1 13CTCTGGACTTGTTTAGTCC31
EF2 399CACAGAGGCACAGCACC383
XF1 268GGTGCTATTGGAGGCTAC285
XF2 356ACTATAACCAGATGCC374
ER1 285GTAGCCTCCAATAGCACC268
XR1 457CTGACATATTGTAGCAGTCC438
XR2 726CGGAACAGTTCAGAATCGG708
FR TGACTAAGCTTGTCGACG
AdT CAGGAAACAGCTATGACTAAGCTTGTCGACGT17
Numbering refers to the cDNA sequence shown in Fig. 1. E pre¢x
indicates primers designed on the EST fragment; X pre¢x indicates
primers designed on our sequence. F, forward; R, reverse; A, an-
chor.
Fig. 1. Nucleotide and deduced amino acid sequences of the cDNA
coding for X. laevis PrP. The ¢rst base of the translation start co-
don is designated +1, the stop codon (TGA) is indicated by an as-
terisk and the putative poly-adenylation signal (TATAAA) is bold.
Ile15 and the ¢rst base of its codon (black boxed) correspond to the
polymorphic site, where, following change of A to G, Val can be al-
ternatively found.
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interrupted by intervening sequences. This preliminary result
suggests, according to known PrP gene structures [17] that the
coding region and 3P-UTR are part of the same exon. Un-
fortunately, up to now we have not been able to further ex-
tend the sequence at 5P, nevertheless, experiments are in pro-
gress to verify the entire gene organization.
3.2. Analysis of the deduced amino acid sequence
A preliminary analysis of some structural features, exhib-
ited by the amino acid sequence deduced from X. laevis
cDNA (Fig. 1), is useful to allow more documented com-
ments.
In our opinion, as remarked above, precursor protein pri-
mary structure starts with Met, corresponding to the second
ATG within cDNA sequence. At this N-terminal end, a se-
quence of 22 amino acids is consistent with an endoplasmic
reticulum signal peptide, where the above mentioned presence
of G or A in the nucleotide sequence involves a substitution,
Ile or Val, at position 15. Occurrence of this conservative
change within the signal peptide, lost in the mature protein,
suggests that it is likely a polymorphic site. This peptide is
followed by a basic region (four lysines out of nine residues)
that would represent the N-terminal end of the mature pro-
tein. The main di¡erence in comparison with all known PrPs
is a complete lack of repeats in this amphibian protein pri-
mary structure. Nevertheless, sequences corresponding to re-
Fig. 3. Schematic representation of relevant prion and Doppel protein features. Numbers refer to positions in amino acid sequences. Boldface
arrows indicate sites of proteolytic cleavage; disul¢de bridges are marked by a line connecting the two involved Cys. N indicates glycosylation
sites; GPI indicates GPI anchor. Dotted lines indicate putative sites.
Fig. 2. Comparison of the X. laevis prion amino acid sequence with those of representative members of higher vertebrate classes. Conserved
amino acids are boxed; gray denotes identical residues.
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gions immediately before and after repeats are present also in
X. laevis or, better, show considerable conservation, especially
when compared to turtle and avian PrP (Fig. 2). A second
signi¢cant di¡erence concerns the hydrophobic stretch, con-
sidered a PrP signature, which is not perfectly conserved in X.
laevis, where, along a sequence of 16 residues, identical in all
known PrPs, there is a deletion of four consecutive amino
acids and some substitutions (Fig. 2).
The C-terminal portion retains all relevant features present
in other PrPs: two cysteines (positions 148 and 185) corre-
sponding to the same residues, conserved in all species, form-
ing usually an intramolecular disul¢de bond; two putative N-
glycosylation sites, the ¢rst (Asn150) corresponds exactly to
the ¢rst modi¢cation site in all PrPs, the second (Asn165),
due to surrounding context, appears to be equivalent to the
extra glycosylation site present in avian PrPs rather than to
the second common site [8,18]. Finally, a peptide of 22^23
amino acids at C-terminal end might be lost in the mature
protein because of the predicted presence of a glycosyl phos-
phatidylinositol (GPI) anchor site, likely at position 193 or
194, where a dipeptide Ser^Gly is present, corresponding to
the same dipeptide in turtle and chicken. In this last case,
Gly249 is thought to be the probable target for GPI addition
[8]. A schematic representation of PrP structural motifs, com-
pared among di¡erent vertebrate classes, is shown in Fig. 3.
3.3. Some comments on X. laevis PrP
The X. laevis protein comprises 216 residues, corresponding
to a calculated molecular mass of 24 344 Da, and is therefore
15^20% shorter with respect to known PrPs, mainly due to
lack of repeats region. On the whole, it shows a higher degree
of identity to avian and turtle (more than 44%) than to mam-
malian PrPs (about 28%). As far as Doppel is concerned [19],
identity level is very low (12^13%), supporting the opinion
that this X. laevis protein is the amphibian version of PrP,
in spite of the fact that absence of repeats and presence of an
imperfect hydrophobic stretch (PrP signature) suggest that it
could be lying between prion and Doppel.
Observations that this novel PrP is completely devoid of
histidine residues, as well as that His content of PrP decreases
with lowering of evolutionary level, are noteworthy, but of
unknown meaning. Histidines represent about 4% of amino
acid residues in mammalian and avian PrP, decrease to 1.5%
in turtle and are absent in X. laevis. Presence of these residues
in the repeats region of mammalian PrP has been reported to
be responsible of Cu2 binding and this behavior has been
considered the basis for some functional hypotheses [20,21].
On the contrary, such ability seems rather questionable for
avian and turtle PrP, suggesting that copper binding could
not be the primary function of the PrP [9,22]. Absence of
both repeats and histidines in X. laevis protein could support
the above hypothesis. A second role for His, in particular for
the His preceding the hydrophobic stretch (corresponding to
His111 of the human sequence in Fig. 2) and conserved both in
mammals and birds, as crucial residue involved in conforma-
tional changes of PrP, has been reported [23]. Moreover, very
recent studies, carried out using the prion peptide PrP 106^
126 (following numbering of human protein), showed that
Cu2 and/or Zn2 binding to the peptide is critical for its
aggregation and neurotoxicity, and that His111 is directly in-
volved in this binding [24]. Since the corresponding His is
present neither in turtle, nor in X. laevis PrP, questions arise
about PrP conformational behavior and neurotoxicity in these
lower vertebrates. The predicted three-dimensional structure
of the X. laevis PrP C-terminal region (Fig. 4) was computed
by a comparative protein modelling software [25]. Unlike the
two short antiparallel L-strands, which are absent in this novel
PrP, the three K-helices, resolved by NMR in PrP of some
mammalian species [6], appear to be well conserved in the
amphibian protein. However, three residues downstream the
¢rst K-helix (H1), a couple of amino acids are predicted to
retain the same secondary structure (H1a), con¢rming that
this region has remarkable tendency to assume this structure.
Isolation and characterization of the ¢rst whole coding se-
quence for an amphibian PrP is here reported. Although fur-
ther work, already in progress, is needed to verify mRNA size,
gene structure as well as the possible presence of prion-like
proteins, analysis of both the X. laevis cDNA sequence and
the deduced protein primary structure led to a further ap-
proach towards PrP origin. This result gives new support to
hypothesis that ancestors of PrP have to be found also in the
most primitive vertebrates.
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